Conference Coverage
Conference Coverage
Treatments explored to ease postviral symptoms of ME/CFS and long COVID
“There aren’t cures, but there are many management techniques to improve symptoms.”
Conference Coverage
Injectable HIV prevention better than pills in two trials
“The incredible efficacy of long-acting PrEP for cisgender women shown by HPTN 084 is game-changing for our practice.”
Conference Coverage
Landmark ALLIANCE results offer tenofovir guidance in HIV/HBV coinfection
“There is hardly any good reason to give the two-pill DTG regimen over single-tablet BTG/TAF/FTC in HBV-coinfected people living with HIV.”
Conference Coverage
Doxycycline cuts STI risk in men and trans women having sex with men
“It is time to take action on the data that we have and really think about incorporating it into guidelines and rolling this out in a safe and...
Conference Coverage
Prolonged remission in patient with HIV may open new avenues to functional cure
“This case opens new avenues in the HIV functional-cure field.”
Conference Coverage
Fourth patient cleared of HIV after stem cell transplant for blood cancer
“Although a transplant is not an option for most people with HIV, these cases are still interesting, still inspiring, and help illuminate the...
Feature
Methotrexate’s impact on COVID-19 vaccination: New insights made
New studies assess patients with various immune-mediated inflammatory diseases to determine the risks and benefits of pausing methotrexate after...
Conference Coverage
‘Myriad’ dermatologic reactions after COVID-19 vaccination
The most common delayed events were pityriasis rosea and lichen planus.
Conference Coverage
U.K. survey: Dermatologists want training in prescribing antipsychotics for delusional infestation
The survey of almost 80 dermatologists found that almost 90% had not prescribed antipsychotics in the previous month for patients with...
Conference Coverage
Skin reactions after COVID-19 vaccination have six patterns
“This is the first study that analyzes a significant number of cases assessed by dermatologists and illustrated with clinical images.”
Conference Coverage
Finding HBV ‘cure’ may mean going ‘back to the drawing board’
Development of new HBV drugs looks more complicated than initially expected, and it’s time to refine and refocus goals, according to one...